Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling

Zachariah E. Selvanayagam, Tak Hong Cheung, Nien Wei, Ragini Vittal, Keith Wing Kit Lo, Winnie Yeo, Tsunekazu Kita, Roald Ravatn, Tony Kwok Hung Chung, Yick Fu Wong, Khew Voon Chin

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Ovarian carcinoma is a leading cause of gynecologic cancer death in women. Despite treatment, a large number of women with ovarian cancer eventually relapse and die of the disease. Hence, recurrent ovarian cancer continues to be a therapeutic dilemma, possibly a result of the emergence of drug resistance during relapse. Recent advances in expression genomics enable global transcript analysis that leads to molecular classification of cancers and prediction of outcome and treatment response. We did a cDNA microarray examination of the expression profiles of eight primary ovarian cancers stratified into two groups based on their chemotherapeutic response. We applied a voice-speech-pattern recognition algorithm for microarray data analysis and were able to model and predict the response of these patients to chemotherapy from their expression profiles. Hence, gene expression profiling by means of DNA microarray may be applied diagnostically for predicting treatment response in ovarian cancer.

Original languageEnglish (US)
Pages (from-to)63-66
Number of pages4
JournalCancer Genetics and Cytogenetics
Volume154
Issue number1
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Fingerprint

Oligonucleotide Array Sequence Analysis
Ovarian Neoplasms
Recurrence
Gene Expression Profiling
Microarray Analysis
Genomics
Drug Resistance
Neoplasms
Therapeutics
Carcinoma
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Selvanayagam, Z. E., Cheung, T. H., Wei, N., Vittal, R., Kit Lo, K. W., Yeo, W., ... Chin, K. V. (2004). Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling. Cancer Genetics and Cytogenetics, 154(1), 63-66. https://doi.org/10.1016/j.cancergencyto.2004.01.024

Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling. / Selvanayagam, Zachariah E.; Cheung, Tak Hong; Wei, Nien; Vittal, Ragini; Kit Lo, Keith Wing; Yeo, Winnie; Kita, Tsunekazu; Ravatn, Roald; Hung Chung, Tony Kwok; Wong, Yick Fu; Chin, Khew Voon.

In: Cancer Genetics and Cytogenetics, Vol. 154, No. 1, 01.10.2004, p. 63-66.

Research output: Contribution to journalArticle

Selvanayagam, ZE, Cheung, TH, Wei, N, Vittal, R, Kit Lo, KW, Yeo, W, Kita, T, Ravatn, R, Hung Chung, TK, Wong, YF & Chin, KV 2004, 'Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling', Cancer Genetics and Cytogenetics, vol. 154, no. 1, pp. 63-66. https://doi.org/10.1016/j.cancergencyto.2004.01.024
Selvanayagam, Zachariah E. ; Cheung, Tak Hong ; Wei, Nien ; Vittal, Ragini ; Kit Lo, Keith Wing ; Yeo, Winnie ; Kita, Tsunekazu ; Ravatn, Roald ; Hung Chung, Tony Kwok ; Wong, Yick Fu ; Chin, Khew Voon. / Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling. In: Cancer Genetics and Cytogenetics. 2004 ; Vol. 154, No. 1. pp. 63-66.
@article{a00230fe5be942f48ba1aa9534f84e99,
title = "Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling",
abstract = "Ovarian carcinoma is a leading cause of gynecologic cancer death in women. Despite treatment, a large number of women with ovarian cancer eventually relapse and die of the disease. Hence, recurrent ovarian cancer continues to be a therapeutic dilemma, possibly a result of the emergence of drug resistance during relapse. Recent advances in expression genomics enable global transcript analysis that leads to molecular classification of cancers and prediction of outcome and treatment response. We did a cDNA microarray examination of the expression profiles of eight primary ovarian cancers stratified into two groups based on their chemotherapeutic response. We applied a voice-speech-pattern recognition algorithm for microarray data analysis and were able to model and predict the response of these patients to chemotherapy from their expression profiles. Hence, gene expression profiling by means of DNA microarray may be applied diagnostically for predicting treatment response in ovarian cancer.",
author = "Selvanayagam, {Zachariah E.} and Cheung, {Tak Hong} and Nien Wei and Ragini Vittal and {Kit Lo}, {Keith Wing} and Winnie Yeo and Tsunekazu Kita and Roald Ravatn and {Hung Chung}, {Tony Kwok} and Wong, {Yick Fu} and Chin, {Khew Voon}",
year = "2004",
month = "10",
day = "1",
doi = "10.1016/j.cancergencyto.2004.01.024",
language = "English (US)",
volume = "154",
pages = "63--66",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling

AU - Selvanayagam, Zachariah E.

AU - Cheung, Tak Hong

AU - Wei, Nien

AU - Vittal, Ragini

AU - Kit Lo, Keith Wing

AU - Yeo, Winnie

AU - Kita, Tsunekazu

AU - Ravatn, Roald

AU - Hung Chung, Tony Kwok

AU - Wong, Yick Fu

AU - Chin, Khew Voon

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Ovarian carcinoma is a leading cause of gynecologic cancer death in women. Despite treatment, a large number of women with ovarian cancer eventually relapse and die of the disease. Hence, recurrent ovarian cancer continues to be a therapeutic dilemma, possibly a result of the emergence of drug resistance during relapse. Recent advances in expression genomics enable global transcript analysis that leads to molecular classification of cancers and prediction of outcome and treatment response. We did a cDNA microarray examination of the expression profiles of eight primary ovarian cancers stratified into two groups based on their chemotherapeutic response. We applied a voice-speech-pattern recognition algorithm for microarray data analysis and were able to model and predict the response of these patients to chemotherapy from their expression profiles. Hence, gene expression profiling by means of DNA microarray may be applied diagnostically for predicting treatment response in ovarian cancer.

AB - Ovarian carcinoma is a leading cause of gynecologic cancer death in women. Despite treatment, a large number of women with ovarian cancer eventually relapse and die of the disease. Hence, recurrent ovarian cancer continues to be a therapeutic dilemma, possibly a result of the emergence of drug resistance during relapse. Recent advances in expression genomics enable global transcript analysis that leads to molecular classification of cancers and prediction of outcome and treatment response. We did a cDNA microarray examination of the expression profiles of eight primary ovarian cancers stratified into two groups based on their chemotherapeutic response. We applied a voice-speech-pattern recognition algorithm for microarray data analysis and were able to model and predict the response of these patients to chemotherapy from their expression profiles. Hence, gene expression profiling by means of DNA microarray may be applied diagnostically for predicting treatment response in ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=4644243615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644243615&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2004.01.024

DO - 10.1016/j.cancergencyto.2004.01.024

M3 - Article

C2 - 15381375

AN - SCOPUS:4644243615

VL - 154

SP - 63

EP - 66

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -